[May 14, 2013] ARCA Biopharma has the Lowest Sales per Share in the Biotechnology Industry (ABIO, AMRN, ANX, AVXL, CHTP) Tweet May 14, 2013 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Biotechnology industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.ARCA Biopharma ranks lowest with a sales per share of $0.00. Following is Amarin with a sales per share of $0.00. ADVENTRX Pharmaceuticals ranks third lowest with a sales per share of $0.00. Anavex Life Sciences follows with a sales per share of $0.00, and Chelsea Therapeutics International rounds out the bottom five with a sales per share of $0.00. SmarTrend recommended that subscribers consider buying shares of Chelsea Therapeutics International on February 20th, 2013 as our technology indicated a new Uptrend was in progress when shares hit $1.64. Since that recommendation, shares of Chelsea Therapeutics International have risen 13.8%. We continue to monitor Chelsea Therapeutics International for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]